129 related articles for article (PubMed ID: 34091531)
1. Does Loss of Immunohistochemical Expression of Glypican 3 in Oral Squamous Cell Carcinoma Play a Role in the Wnt/β-catenin Signaling Pathway?
Jot K; Urs AB; Kumar P
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):693-699. PubMed ID: 34091531
[TBL] [Abstract][Full Text] [Related]
2. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma.
Schlaepfer Sales CB; Guimarães VSN; Valverde LF; Dias RB; Freitas RD; Siquara da Rocha LO; Coelho de Miranda M; Vilas Bôas DS; Gonçalves Agra IM; Dos Santos JN; Gurgel Rocha CA
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):345-351. PubMed ID: 33512817
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
Bi Y; Jiang Y; Li X; Hou G; Li K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma.
Wang D; Gao Y; Zhang Y; Wang L; Chen G
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
[TBL] [Abstract][Full Text] [Related]
6. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
7. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
9. Implications of Differential Expression of β-Catenin in Oral Carcinoma.
Moles MA; Montoya JA; Salvago MD; Ávila IR; Campillo JJ; Bravo M
Anticancer Res; 2016 Apr; 36(4):1599-604. PubMed ID: 27069136
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
Lyu Q; Jin L; Yang X; Zhang F
Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
[TBL] [Abstract][Full Text] [Related]
11. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
Prgomet Z; Andersson T; Lindberg P
Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
[TBL] [Abstract][Full Text] [Related]
13. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
Zargaran M
Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
[TBL] [Abstract][Full Text] [Related]
14. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
16. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.
Ai Y; Wu S; Zou C; Wei H
J Cell Mol Med; 2020 Sep; 24(18):10512-10524. PubMed ID: 32691935
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
Cui SH; Hu XD; Yan Y
J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
[TBL] [Abstract][Full Text] [Related]
19.
Huang C; Wang L; Song H; Wu C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
[No Abstract] [Full Text] [Related]
20. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
